1761. A Single-Center Experience with Cidofovir for the Treatment of Double-Stranded (ds) DNA Viruses in Hematopoietic Cell Transplant (HCT) Recipients

BACKGROUND: Cidofovir (CDV), a nucleotide analog antiviral, is active against multiple dsDNA viruses relevant in HCT recipients. Despite a broad spectrum of activity, CDV utility is limited due to nephrotoxicity. We describe our experience with CDV in a large contemporary cohort from a single Instit...

Descripción completa

Detalles Bibliográficos
Autores principales: Stern, Anat, Su, Yiqi, Neofytos, Dionysis, Papanicolaou, Genovefa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809354/
http://dx.doi.org/10.1093/ofid/ofz360.1624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809354/
http://dx.doi.org/10.1093/ofid/ofz360.1624

Ejemplares similares